Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DaVita HealthCare Partner (NY:DVA)

142.20 -0.36 (-0.25%)
Streaming Delayed Price Updated: 3:36 PM EDT, Jul 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DaVita HealthCare Partner

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Which S&P500 stocks are moving before the opening bell on Friday?
Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on S&P500 stock movements. 
Via Chartmill
Applied Materials, Informatica, Clearwater Paper And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
DaVita Plunges Over 10% In Friday Pre-Market After Warren Buffett Cuts Stake In One Of Berkshire Hathaway's Longest-Held Investments
The shares of DaVita Inc.(NYSE: DVA) plunged 10.2% in pre-market hours trading on Friday after Berkshire Hathaway trimmed its stake in the company. The dialysis provider also issued a weak outlook for... 
Via Benzinga
Warren Buffett's Berkshire Hathaway Sells Nearly $36 Million Worth Of Dialysis Giant DaVita's Shares Amid Q4 Earnings Beat
Warren Buffett's Berkshire Hathaway has cut its stake in the dialysis provide DaVita Inc according to a U.S. SEC filing. 
Via Benzinga
Topics Regulatory Compliance
Earnings Scheduled For February 13, 2025
Via Benzinga
What Analysts Are Saying About DaVita Stock
Via Benzinga
Key Takeaways From DaVita Analyst Ratings
Via Benzinga
DaVita (DVA) Q4 2024 Earnings Call Transcript
DVA earnings call for the period ending December 31, 2024. 
Via The Motley Fool
Topics Earnings
DaVita (NYSE:DVA) Posts Better-Than-Expected Sales In Q4 But Stock Drops
Dialysis provider DaVita Inc. (NYSE:DVA) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 4.7% year on year to $3.29 billion. Its non-GAAP profit of $2.24 per share was 4.3% above... 
Via StockStory
DaVita (DVA) Reports Q4: Everything You Need To Know Ahead Of Earnings
Dialysis provider DaVita Inc. (NYSE:DVA) will be announcing earnings results tomorrow after market close. Here’s what to look for. 
Via StockStory
2 Warren Buffett Stocks to Buy Without Hesitation If You Have $1,000 to Invest Right Now
Via The Motley Fool
3 No-Brainer Warren Buffett Stocks to Buy Right Now
Via The Motley Fool
The Best Warren Buffett Stocks to Buy With $250 Right Now
Via The Motley Fool
DaVita Stock Sees Improved Relative Strength Rating
DaVita stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 64 to 72. 
Via Investor's Business Daily
The Best Warren Buffett Stocks to Buy With $1,000 Right Now
Here are three of Warren Buffett's highest-conviction stocks. 
Via The Motley Fool
Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul
Evolent Health, Kronos Bio, Saint-Gobain, Shell and Unilever are on the sell-side this week. Benzinga's Deal Dispatch has the latest M&A updates. 
Via Benzinga
Golden Years For M&A Deals Ahead Under Trump? Analysts Highlight Top 10 Large-Cap Candidates
GOP control of Congress under Trump could lead to a surge in M&A activity, especially in banks and biotech. Factors like equity market returns and rate cuts could fuel deals, with small-cap targets and... 
Via Benzinga
Topics Government
Why DaVita Stock Withered on Wednesday
The company's profitability is going in the wrong direction for many investors. 
Via The Motley Fool
Two Warren Buffett Stocks Get Pounded, With Apple Earnings Due
This week marks a firehose of earnings from several top Buffett holdings. 
Via Investor's Business Daily
DaVita (DVA) Q3 2024 Earnings Call Transcript
DVA earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
3 Buy Rated Stocks Cruising At 52 Week Highs
Stocks making new highs tend to make even higher highs, particularly when analysts' positive earnings estimate revisions are rolling in. Let’s take a closer look at what’s been driving the bullish... 
Via Talk Markets
AdaptHealth Stock Earns RS Rating Upgrade
AdaptHealth stock saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, rising from 70 to 81. 
Via Investor's Business Daily
3 Red Hot Stocks Flashing Buy Signals: DaVita, Intuitive Surgical, SharkNinja
Stocks making new highs tend to make even higher highs, particularly when analysts' positive earnings estimate revisions come rolling in. That’s been precisely the case for Intuitive Surgical,... 
Via Talk Markets
Bull Of The Day: Davita - Friday, September 6
Known to be the most volatile month for stocks, September is when many investors rebalance their portfolios to include less risky assets such as equities that provide exposure to essential healthcare... 
Via Talk Markets
Top Medical Stocks To Hedge Against The September Effect
While the Fed will likely cut interest rates in the coming weeks, September has historically been the most challenging month for stocks. Here are three top medical stocks to hedge against the September... 
Via Talk Markets
Topics Economy
Nvidia is Down 21%. Here Are 3 Better Stocks to Buy for the Rest of 2024
The AI chipmaker has enjoyed a tremendous run-up, but its sky-high valuation means there are better stocks to buy than Nvidia. 
Via InvestorPlace
Topics Artificial Intelligence
DaVita (DVA) Q2 2024 Earnings Call Transcript
DVA earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
DVA Stock Earnings: DaVita Beats EPS, Beats Revenue for Q2 2024
DVA stock results show that DaVita beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Financial Crime Weekly: DaVita Agrees To Pay $34.5M For Kickbacks, Hospice Provider Doles Out $19.4M For False Claims
DaVita Inc., a kidney dialysis provider, will pay $34.5 million for allegedly paying kickbacks to competitors and doctors for patient referrals. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.